Cardiac Stem Cells

A new review describes the interplay between cardiac ECM and stem and progenitor cells during the response to ischemic heart diseases

Researchers report the decoding of the secretome of clinical trial-biobanked cardiopoietic cells and link innate secretome traits with therapeutic outcomes

Intracellular MMP9 expression aids the differentiation of human cardiac stem cells via epigenetic modifications and autophagy

A new review discusses the prospects for reinstating full embryonic potential in the adult epicardium to facilitate cardiac regeneration

Neonatal cardiac tissue stem‐like cells express metabolism-related genes that increase functional properties

A recent review article discusses the therapeutic benefit of exosomes secreted by stem and progenitor cells in preclinical models of ischemic heart disease

Despite the considerable interest in defining the transcriptional profiles of human cardiac cells at single‐cell resolution, data regarding the transient stages of early human cardiac progenitor cell development have remained elusive.

New research highlights the zinc-finger of the cerebellum 2 (ZIC2) gene as an essential factor in the formation of human cardiac progenitor cells from embryonic stem cells

A study reveals proteome remodeling within the infarcted heart and establishes that cardiopoietic stem cell therapy can reverse disease-associated proteomic changes

To reveal the regulators that control the formation of human cardiac progenitor cells without bias, researchers led by Kenneth R.